Carle has received two essential approvals in the acquisition of Advocate BroMenn Medical Center, Advocate Eureka Hospital and affiliated sites.
The Illinois Health Facilities and Services Review Board (HFSRB) has approved the Certificate of Exemption (COE) application for BroMenn and Eureka. In addition, Carle and Advocate have cleared a regulatory requirement with Federal Trade Commission (FTC) approval moving toward the acquisition of Advocate BroMenn, Advocate Eureka and affiliated medical group sites.
In early 2020, Carle and Advocate Aurora Health entered into an agreement for the central Illinois facilities to join Carle.
“We look forward to bringing expanded access to health care services in the central Illinois region,” said Charles Dennis, MD, Carle executive vice president and chief medical officer. “We are one step closer to welcoming the Advocate BroMenn, Eureka, Medical Group and clinical teams to Carle Health and providing continued high quality care to those in our communities. Despite the pressures on both systems given the COVID crisis, each has remained focused on the successful completion of this transaction in order to bring expanded access to health care services to the central Illinois region.”
Next steps include finalizing the COE applications for The Center for Outpatient Medicine (TCOM) and BroMenn Comfort and Care Suites. The transaction is scheduled to close on July 1, 2020.
Categories: News
Tags: Bloomington, Bloomington-Normal, BroMenn, Eureka, growth, patients